Mitochondria in cancer metabolism, an organelle whose time has come?

Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):96-102. doi: 10.1016/j.bbcan.2018.05.005. Epub 2018 May 26.

Abstract

Mitochondria have long been controversial organelles in cancer. Early discoveries in cancer metabolism placed much emphasis on cytosolic contributions. Initial debate focused on if mitochondria had a role in cancer formation and progression at all. More recently the contributions of mitochondria to cancer development and progression have become firmly established. This has led to the identification of novel targets and inhibitors being studied as new therapeutic approaches. This review will summarize the role of mitochondria in cancer and highlight several agents under development.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / drug effects
  • Cell Proliferation
  • Citric Acid Cycle / drug effects
  • Electron Transport / drug effects
  • HSP90 Heat-Shock Proteins / antagonists & inhibitors
  • Mitochondria / drug effects*
  • Mitochondria / genetics
  • Mitochondria / metabolism*
  • Mitochondrial Dynamics / drug effects
  • Neoplasms / metabolism*
  • Protein Biosynthesis / drug effects

Substances

  • Antineoplastic Agents
  • HSP90 Heat-Shock Proteins